Literature DB >> 18194904

Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease.

Chia-Yen Chen1, Yung-Ming Liao, Wei-Ming Tsai, Hann-Chorng Kuo.   

Abstract

BACKGROUND/
PURPOSE: This study investigated the incidence of upper urinary tract urothelial carcinoma (UUT-UC) in eastern Taiwan and its association with chronic kidney disease (CKD).
METHODS: A total of 110 patients with histologically proven UUT-UC over a recent 20-year period were retrospectively analyzed to determine the clinical profile, overall survival and correlation with CKD.
RESULTS: The mean age at diagnosis was 68.7 +/- 9.8 years (range, 43-93 years), and the male to female ratio was 1 to 1.16 (51:59). The ratio of urothelial carcinoma (UC) of the renal pelvis to UC of the ureter to UC of the bladder was 1.2:1:6.7. UC of the renal pelvis accounted for 10.8% of all urinary tract UC, and for 41% of all renal cancer detected during the study period. The 2-, 5- and 10-year cancer-specific survival rates of patients with UUT-UC were 75%, 53.0% and 29%, respectively. Patients with high grade and high stage UUT-UC had significantly worse prognosis than those with low grade (p = 0.0047) and low stage (p = 0.0021). Of the 110 patients, 64 (58%) had impaired renal function (glomerular filtration rate < 60 mL/min/1.73 m2; defined as CKD), including 14 (13%) with end-stage renal disease (ESRD) before diagnosis. Patients with CKD or ESRD had significantly worse prognosis than those with normal renal function (p = 0.0399). High grade UC was found in 35 of 58 patients with CKD or ESRD (60%), which was significantly higher than in patients with normal renal function (12/26, 26%; p = 0.019).
CONCLUSION: A high proportion of UUT-UC was observed among all UCs and a significantly higher percentage of high grade UUT-UC (60%) were found in patients with CKD or ESRD in eastern Taiwan. These findings suggest that CKD and ESRD might play a role in the development of UC especially in the upper urinary tract.

Entities:  

Mesh:

Year:  2007        PMID: 18194904     DOI: 10.1016/S0929-6646(08)60074-1

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  18 in total

1.  Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort.

Authors:  Pei-Hsuan Weng; Kuan-Yu Hung; Hsien-Liang Huang; Jen-Hau Chen; Pei-Kun Sung; Kuo-Chin Huang
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

2.  Long-term outcome of radical cystectomy in ESDR patients with bladder urothelial carcinoma.

Authors:  Shu-Fen Tseng; Yao-Chi Chuang; Wen-Chou Yang
Journal:  Int Urol Nephrol       Date:  2011-04-24       Impact factor: 2.370

3.  Prognostic significance of PD-L1 expression on tumor cells and tumor-infiltrating mononuclear cells in upper tract urothelial carcinoma.

Authors:  Bo Zhang; Wei Yu; Xueru Feng; Zheng Zhao; Yu Fan; Yisen Meng; Shuai Hu; Yun Cui; Qun He; Hong Zhang; Dong Li; Zhisong He; Liqun Zhou; Jie Jin; Wenke Han
Journal:  Med Oncol       Date:  2017-04-13       Impact factor: 3.064

Review 4.  Onco-nephrology: an appraisal of the cancer and chronic kidney disease links.

Authors:  Hassan Izzedine; Mark A Perazella
Journal:  Nephrol Dial Transplant       Date:  2015-02-03       Impact factor: 5.992

5.  Aristolochic acid-associated urothelial cancer in Taiwan.

Authors:  Chung-Hsin Chen; Kathleen G Dickman; Masaaki Moriya; Jiri Zavadil; Viktoriya S Sidorenko; Karen L Edwards; Dmitri V Gnatenko; Lin Wu; Robert J Turesky; Xue-Ru Wu; Yeong-Shiau Pu; Arthur P Grollman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

6.  New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid.

Authors:  Byeong Hwa Yun; Viktoriya S Sidorenko; Thomas A Rosenquist; Kathleen G Dickman; Arthur P Grollman; Robert J Turesky
Journal:  Toxicol Res (Camb)       Date:  2015-07-01       Impact factor: 3.524

7.  Prevalence, clinicopathological features, and prognosis in upper tract urinary carcinoma patients with severe preoperative chronic kidney disease.

Authors:  Zhengqing Bao; Yicong Du; Yiming Yuan; Yuze Zhu; Cheng Qian; Yonghao Zhan; Dong Fang; Gengyan Xiong; Lei Zhang; Xuesong Li; Liqun Zhou
Journal:  Transl Androl Urol       Date:  2019-12

8.  Prognostic Significance of Preoperative Albumin-Globulin Ratio in Patients with Upper Tract Urothelial Carcinoma.

Authors:  Bo Zhang; Wei Yu; Li-Qun Zhou; Zhi-Song He; Cheng Shen; Qun He; Jun Li; Li-Bo Liu; Cong Wang; Xiao-Yu Chen; Yu Fan; Shuai Hu; Lei Zhang; Wen-Ke Han; Jie Jin
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

Review 9.  Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge.

Authors:  Li-Jen Wang; Shen-Yang Lee; Bin Tean Teh; Cheng-Keng Chuang; Joëlle Nortier
Journal:  Biomed Res Int       Date:  2014-08-07       Impact factor: 3.411

10.  Preoperative Plasma Fibrinogen Level Represents an Independent Prognostic Factor in a Chinese Cohort of Patients with Upper Tract Urothelial Carcinoma.

Authors:  Bo Zhang; Yi Song; Jie Jin; Li-Qun Zhou; Zhi-Song He; Cheng Shen; Qun He; Jun Li; Li-Bo Liu; Cong Wang; Xiao-Yu Chen; Yu Fan; Shuai Hu; Lei Zhang; Wei Yu; Wen-Ke Han
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.